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a  b  s  t  r  a  c  t
Myracrodruon  urundeuva  Allemão,  Anacardiaceae,  is  a medicinal  plant  widely  found  in Brazil,  especially
in  the  northern  region.  In our  previous  study,  the ethanolic  extract  from  leaves  of  M.  urundeuva  showed
antiviral  activity  against  simian  rotavirus  SA-11.  Here,  the crude  extract  was  subjected to  fractionations  in
order to subsequently  work  with  more  concentrated  and  pure  bioactive  compounds,  which  were  analyzed
by TLC  and  HPLC  methods  to support  a better  understanding  of  their  virucidal  effect.  The  antiviral  activity
was  evaluated  using  a rotavirus  infection  model  in MA-104  cells  treated  with  the  maximum  non-cytotoxic
concentration  of the crude  extract  and  its fractions.  Data  were  expressed  as  the  percentage  inhibition  of
viral replication  calculated  by  the  inhibition  of  cytopathic  effect  in the  treated  cells  compared  to untreated
controls  after  48  h of  incubation.  First,  we conducted  a  fractionation,  generating  ﬁve  fractions  (F1–F5)
which  were  submitted  to antiviral  assay.  Then,  the  fraction  that  showed  the  highest  virucidal  effect  (F3,
PI = 75%)  was  subjected  to  a larger  partition,  yielding  eighteen  subfractions,  which  were  submitted  to
new  antiviral  assays.  Terpenes,  ﬂavonoids  and tannins  were  the major  secondary  metabolites  detected
by  TLC  analysis  in  F3. SF1,  a ﬂavonoid-enriched  fraction,  showed  the  strongest  in  vitro  activity  against
rotavirus  (PI  = 92%),  preventing  cytopathic  effect.  Chromatographic  proﬁles  were  obtained  by HPLC  for  the
crude extract  and SF1,  the  most  potent  subfraction.  Overall,  our  data  point  to the  potential  anti-rotavirus
activity  of  ﬂavonoid-enriched  fraction  (SF1)  of M. urundeuva  leaves,  corroborating  the  traditional  use of
this species  to treat  diarrhea  and  broadening  our  perspectives  on  in  vivo  assays  in mice  with  SF1  isolated
or  associated  with  other  fractions.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Rotaviruses are recognized as a major cause of non-bacterial
astroenteritis especially in infants and young children worldwide
Parashar et al., 2006; Junaid et al., 2011). It is an unpredictable
isease highly contagious and may  lead to severe dehydration and
ven death (Ofﬁt and Clark, 2000). Its transmission is person to
erson through the fecal-oral route. Control and prevention of this
nfection are difﬁcult due to the lack of any effective treatment
ther than palliative measures and the presence of asymptomatic
hildren shedding virus (Dennehy, 2000). Despite two live oral
otavirus vaccines that have already been licensed, a monovalent
uman rotavirus vaccine (Rotarix, GlaxoSmithKline Biologicals)
nd a pentavalent bovine-human reassortant rotavirus vaccine
RotaTeq, Merck), their effectiveness in developing countries has
∗ Corresponding author.
E-mail: alzira.cecilio@funed.mg.gov.br (A.B. Cecílio).
http://dx.doi.org/10.1016/j.bjp.2015.10.005
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorashown a pooled efﬁcacy of about 51% requiring efforts to optimize
(Jiang et al., 2010).
Nevertheless, in several cases, where the host is suffering from
prolonged diarrhea and fever, virus-speciﬁc treatment will be nec-
essary if possible (Takahashi et al., 2001). Natural products have
been the source of most of the active ingredients of medicines
and more than 80% of drug substances were natural products or
inspired by a natural compound (Harvey, 2008). In this context,
in vitro assays have been established and used by our research
group to screen antiviral activities of extracts, fractions and natural
substances with potential therapeutical action.
In previous work, using similar methodology employed here,
we evaluated ethanolic crude extracts of different Brazilian medic-
inal plants and we observed an in vitro anti-rotavirus activity of
Myracrodruon urundeuva Allemão, Anacardiaceae (Cecílio et al.,
2012), a medicinal plant widely used in Brazil, mainly due to its
anti-inﬂammatory, antimicrobial and wound healing properties
(Monteiro et al., 2006; Souza et al., 2007; Sá et al., 2009a). This plant
is a representative species of the Anacardiaceae family occurring in
 Ltda. All rights reserved.
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razil and other South American countries, notably in the Cerrado
egion (Leite, 2002).
Analgesic, anti-inﬂammatory, antioxidant, antifungal, and
ntibacterial, among other activities, have been reported from
reparations made with M.  urundeuva extracts. Viana et al. (1997,
003) have observed analgesic and anti-inﬂammatory effects of
he tannin and chalcones fractions isolated from M. urundeuva
arks in studies conducted in mice. Souza et al. (2007) have also
hown that tannin-enriched fraction from stem bark of this plant
resents anti-inﬂammatory and antiulcer effects in mice, partly
ue to its antioxidant action, known to be present in polyphenols,
ncluding tannins. Interestingly, De Mendonc¸ a Albuquerque et al.
2011) demonstrated inhibition of myeloperoxidase activity and
ntioxidant effects of chalcones from M.  urundeuva stem barks on
n allergic conjunctivitis model in guinea pig, indicating them as
andidates for the treatment of allergic conjunctivitis and other
nﬂammatory conditions.
According to Sá et al. (2009a), lectins isolated from M.  urun-
euva heartwood showed antimicrobial activity against bacteria
nd fungi that attack plants, including woods. In addition, stem bark
ydroethanolic extract was active against Staphylococcus aureus,
lebsiella pneumonia,  Enterococcus faecalis and Candida spp. (Alves
t al., 2009; Gomes et al., 2013), and these activities were attributed
o the presence of bioactive compounds such as tannins, ﬂavonoids
nd alkaloids.
Furthermore, experiments in rats that point to anti-diarrheal
Chaves et al., 1998) and neuroprotective activities (Nobre-Júnior
t al., 2009), colonic anastomotic healing (Goes et al., 2005), and
ven larvicidal effect against Aedes aegypti (Napoleão et al., 2012)
nd termite repellent action (Sá et al., 2009b) show the biologi-
al potential of this plant, which hides a rich source of compounds
hat could be employed to therapeutic and biotechnological appli-
ations, among other purposes.
Considering the pharmacological potential of M. urundeuva and
ur previous data of anti-rotavirus activity (Cecílio et al., 2012),
he crude extract from the leaves of this plant was fractionated and
ubjected to antiviral assay, being the active fractions characterized
y TLC method in an attempt to identify the bioactive compounds
nvolved in the virucidal effect.
aterial and methods
lant material
Myracrodruon urundeuva Allemão, Anacardiaceae, leaves were
ollected from adult plants in the “cerrado” area of Santana do Pira-
ama, in the State of Minas Gerais, Brazil, between September 2006
nd February 2007. The plant was identiﬁed as a voucher specimen
nd was deposited at the Herbário PAMG da Empresa de Pesquisa
gropecuária de Minas Gerais under the number PAMG 53312.
reparation of extract and fractionation
The crude extract (MUL) was prepared by percolation of the
ried and powdered material with ethanol 95 GL (Vetec Química
ina) until exhaustion at room temperature and evaporated under
educed pressure at 40 ◦C. The ethanolic extract (250 g) was  frac-
ioned by ﬁltration chromatography in silica gel (silica gel 60,
.040–0.063 mm,  Merck), giving ﬁve fractions after elution with
exane (F1, 30 g), dichloromethane (F2, 21 g), dichloromethane-
thyl acetate (1:1) (F3, 14.7 g), ethyl acetate (F4, 45.5 g) and
ethanol (F5, 120 g). A portion of the most potent fraction, F3
10 g), was further fractioned in a silica gel column (silica gel
0, 0.040–0.063 mm,  Merck), with solvents of increasing polari-
ies (dichloromethane, ethyl acetate, ethyl acetate, methanol, waterrmacognosia 26 (2016) 197–202
and formic acid 1% and mixtures of these), yielding eighteen sub-
fractions. SF1 (47 mg), obtained with DCM:EtOAc (1:1), showed the
best antiviral activity and its chemical composition was  evaluated
by TLC and HPLC proﬁles. The low amount obtained prevented fur-
ther fractionation.
Phytochemical screening
MUL, fractions (F1–F5) and the subfraction SF1 were subjected
to phytochemical screening to determine the presence of different
classes of natural products using methods described by Wagner and
Bladt (2001). The analysis was  performed by thin-layer chromatog-
raphy (TLC) on Merck silica gel 60 F254 aluminum plates, which
were developed according to Table 1. The presence of tannins was
determined using a protein precipitation test (Matos, 1997).
HPLC analysis
MUL  and SF1 were prepared at 10 mg/ml  and at 5 mg/ml in
MeOH HPLC grade, respectively (Vetec Química Fina). After cen-
trifugation at 9300 × g (Eppendorf, model, 5415D) the solution
was injected in an Agilent Technologies 1200 series HPLC sys-
tem equipped with DAD detector. Chromatographic analysis was
obtained in a Zorbax XDB C18 column (50 × 4.6 mm,  1.8 m),  at
40 ◦C, ﬂow rate of 0.3 ml/min and detection at  210 nm.  The proﬁles
were obtained in linear gradient elution of water (A) and acetoni-
trile (B), from 15 to 90% of B from 0 to 50 min, and from 90 to 95%
of B between 50 and 60 min. The UV spectra were recorded online
in the 190–400 nm range for all retention times.
Biological assays
Sample preparation
For the bioassays, each sample was  solubilized in dimethyl-
sulfoxide (DMSO, Sigma–Aldrich) at 50 mg/ml  and centrifuged at
9300 × g (Eppendorf, model, 5415D). The samples were diluted to
work concentration using culture media.
Cells and viruses
MA-104 cells (a rhesus monkey kidney cell line) were cultivated
in Dulbecco’s modiﬁed Eagle media (DMEM) supplemented with
10% fetal bovine serum (FBS), 100 g/ml of streptomycin (Gibco)
and 100 U/ml penicillin G (Invitrogen). The cell cultures were main-
tained at 37 ◦C in a humidiﬁed 5% CO2 atmosphere. Simian rotavirus
SA11 were activated with 10 g/ml trypsin for 60 min at 37 ◦C and
propagated in MA-104 cells monolayers in the presence of 10 g/ml
trypsin. The virus titers were estimated from cytopathogenicity
by the limit-dilution method and expressed as 50% tissue culture
infectious dose per ml  (TCID50/ml) (Reed and Muench, 1938).
Cytotoxicity
The cytotoxicity of the samples (MUL, fractions and subfrac-
tions) was  determined using the method described by Miranda et al.
(1999) based on cellular morphologic alterations. Several concen-
trations (5000, 500, 50, 5 and 0.5 g/ml) of samples were placed in
contact with conﬂuent MA-104 cells monolayers prepared in 12-
well microplates and were incubated at 37 ◦C in a humidiﬁed 5%
CO2 atmosphere for 48 h. After the incubation period, the cells were
examined using an inverted optical microscope (Nikon) and treated
and untreated cultures (control) were compared. The higher con-
centration of each extract showing no cellular morphologic changes
was considered as the maximum non-toxic concentration (MNTC)
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Table  1
TLC conditions to test the presence of different classes of natural products in the ethanolic extract.
Class Eluent Spray
Tannins Toluene: acetic acid: formic acid (70:167:14) K3Fe(CN)6 1%: FeCl3 2% (1:1)
Flavonoids Ethylacetate: methanol: water (176:22:22) AlCl3 reagent (2%)
Anthraquinones Toluene: acetone: chloroform (40:25:35) KOH reagent (5%)
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phological alterations including detachment of cells from their
substratum and disruption of cell monolayer, compared with
healthy control cells (Fig. 1C).
Table 2
Maximum non-toxic concentration (MNTC) and percent inhibition of rotavirus (PI)
in  MA-104 cells treated with crude extract (MUL) from Myracrodruon urundeuva leaf
and its fractions (F) and subfractions (SF).
Selected materials MNTC (g/ml) PI (%)
Crude extract
MUL  500 100
Fractions
F1  50 0
F2  5 21
F3  50 75
F4  50 21
F5  50 68
Subfractions
SF1  50 92.06
SF2  50 0
SF3  5 80.05
SF4  5 0
SF5  50 68.38
SF6  5 36.90
SF7  50 20.57
SF8  50 20.57
SF9  50 0
SF10  50 0
SF11  50 0
SF12  50 20.57
SF13 50 0
SF14  50 0Terpenes Hexane: ethylacetate (1:1) 
Cardiotonic glycosides Ethylacetate: methanol: water (20:3:2) 
Alkaloids Ethylacetate: formic acid: acetic acid: water:
nd was conﬁrmed using Promega’s CytoTox 96® Non-Radioactive
ytotoxicity Assay, according to the manufacturer’s instructions.
ntiviral assay
Antiviral activity was evaluated based on the ability of samples
o diminish the multiplication of the virus, including inhibiting
he cytopathic effect (CPE) of rotavirus on treated MA-104 cells
onolayers (4 × 104 cells/well) cultivated in 96-well microplates.
hus, MUL  and fractions (at MNTC) were added to the cells, fol-
owed by the addition of 10 TCID50 of activated rotaviruses, and
he plates were incubated in a 5% CO2 atmosphere at 37 ◦C for 48 h.
he antiviral activity was expressed as a percentage of inhibition
PI) (Miranda et al., 1999) using antilogarithm values of TCID50
or rotavirus, as follows: PI = [1 − (antilogarithm T/antilogarithm
)] × 100 being “T” viral titer of treated cells and “C” viral titer of
ntreated cells (positive control). Experiments were carried out in
ctoplicate. The presence of rotavirus was also veriﬁed by RT-PCR.
NA extraction
Supernatants from the antiviral assays were submitted to RNA
xtraction by a modiﬁed silica method (Boom et al., 1990). Brieﬂy,
0 l of each sample was treated with 200 l lysis buffer (60 g
uanidine isothiocyanate, Invitrogen, 50 ml  of 0.1 M Tris–HCl pH
.4, Invitrogen, 11 ml  of 0.2 M EDTA pH 8.0, Invitrogen, 1.3 g of
riton X-100, Packard Instrument Co.) and 50 l of sterilized sil-
ca solution (prepared according to Boom et al., 1990). After being
entrifuged, the silica was washed with a washing buffer (60 g
uanidine isothiocyanate) (Invitrogen), 50 ml  of 0.1 M Tris–HCl
H 6.4 (Promega), followed by two washes with 70% ethanol
Merck) and acetone (Merck). The material was resuspended in
ater treated with diethyl pyrocarbonate 0.1%, and after being cen-
rifuged, the RNA was collected in the upper phase and maintained
t −80 ◦C until required.
DNA synthesis
The cDNA synthesis was conducted in a 20 l reaction contain-
ng 7% dimethyl sulfoxide, 7 l of viral RNA and 1 M of the primers
ota A – Fwd  1: 5′GGATGTCCTGTACTCCTTGTCAAAA3′ and Rota A
 Rev 1: 5′TCCAGTTTGGAACTCATTTCCA3′, which amplify a 144-bp
roduct (Logan et al., 2006) from rotavirus VP6 region. The reac-
ion was incubated at 95 ◦C for 5 min  and then chilled on ice for
 min. Next, 1× reaction buffer was added, 3 mM MgCl2, 0.5 mM of
ach dNTP and 1 l Improm IITM Reverse Transcriptase (Promega).
inally, the reaction was incubated for 5 min  at 25 ◦C, 60 min  at
2 ◦C, and the enzyme was inactivated for 15 min  at 70 ◦C. The
DNAs were maintained at −80 ◦C until required.
CR assayThe PCR assay was conducted in a reaction of 50 l containing
 l of cDNA, 22 mM Tris–HCl pH 8.4, 55 mM KCl, 1.65 mM MgCl2,
20 M each deoxynucleoside triphosphate (dNTP), 800 nM of the
ame primers used in the cDNA synthesis and 0.5 U recombinantAnisaldehyde-sulfuric acid reagent
Kedde reagent
methylcetone (86:16:23:47:78) Dragendorff reagent
Taq DNA Polymerase (Invitrogen). The cycling program consisted of
an initial denaturation at 95 ◦C for 10 min, followed by 30 cycles of
95 ◦C for 15 s, 60 ◦C for 1 min  and 70 ◦C for 1 min. Each reaction set
contained the reference sample SA11 as a positive control. Nega-
tive control consisted of a reaction with all reagents included and
water instead of cDNA. Then, 10 l of the PCR ampliﬁed product was
analyzed on a silver-stained 8% polyacrylamide gel electrophoresis
(PAGE).
Results
Determining the maximum non-cytotoxic concentration
To carry out the in vitro antiviral assays, we  ﬁrst determined the
concentration of MUL  and fractionated samples that could be used
without causing damage to the cell, based on cellular morphologic
alterations and Promega’s CytoTox Assay data. The maximum non-
toxic concentrations (MNTC) observed were 500 g/ml for MUL,
and 50 g/ml for most of the generated fractions, except for F2 and
SF3, 4, 6 and 15, which showed MNTC at 5 g/ml (Table 2).
Fig. 1A shows a cytotoxic effect characterized by typical mor-SF15  5 0
SF16  50 0
SF17  50 60.19
SF18 50 0
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nfected with the simian rotavirus SA11. (C) Uninfected and untreated control cells
ntiviral assays
The MNTC of the samples were used to conduct the antiviral
ssays to assess their potential activity against rotavirus. Based on
ytopathic effect, we determined the percent inhibition (PI) of the
amples on the replication of rotavirus. There were no cytopathic
ffects (CPE) in cells treated with the MUL. However, we observed
PE (data not shown) and different PI (ranging from 0 to 75%) in the
ells treated with the fractions (Table 2). Thus, the fraction with the
ighest PI (F3, PI = 75%) was selected for further fractionation. The
ests with the subfractions revealed that none of them were able
o inhibit 100% of viral replication, and most of them showed no
ntiviral effect. Interestingly, SF1 (a subfraction from F3) showed
he highest PI (92%), even higher than F3 (Table 2). Fig. 1B shows the
ypical CPE induced by the virus in MA-104 cells. The morpholog-
cal data observed in optical microscopy were consistent with the
olecular data assayed by RT-PCR. The results of the ampliﬁcations
ere visualized in a silver-stained 8% polyacrylamide gel showing
he band corresponding to the 144-bp from rotavirus VP6 region.
hytochemical and HPLC analysis
MUL, F1–F5 and SF1 were subjected to phytochemical analy-
is to determine the main classes of natural products which could
e involved in the antiviral activity. Tannins, ﬂavonoids and ter-
enes were detected in MUL. F1 and F2 showed terpenes, F4
nd F5 showed ﬂavonoids and tannins, and F3 showed terpenes,
avonoids and tannins (Table 3). Because F3 showed the highest
I, it was selected for an additional fractionation, yielding eigh-
een subfractions. Then, SF1, the subfraction with the highest PI,
as also analyzed, revealing ﬂavonoids and terpenes. Finally, chro-
atographic proﬁles of MUL  and SF1 were obtained by HPLC. MUL
howed a predominance of compounds of low polarity as shown in
ig. 2A. SF1, which had the highest antiviral activity, showed peaks
istributed throughout the chromatogram, indicating the presence
f compounds with different polarities. Most of the compounds
ere eluted with retention time lower than 20 min. In this timeange, we observed two major peaks (r.t. of 17.16 and 18.84 min)
ith UV proﬁle characteristic of ﬂavonoids (Fig. 2B). This fraction
lso showed peaks with retention time higher than 40 min, which
ad low UV absorption, with maximum absorption at ca. 210 nm.
able 3
hytochemical screening and yield of crude ethanolic extract (MUL), fractions (F) and sub
Selected materials Extract yield (%, w/w) Tan 
MUL  19.4 + 
F1  12.0 − 
F2  8.4 − 
F3  5.9 + 
F4  18.2 + 
F5  48.0 + 
SF1  0.5 − 
an: tannins; Fla: ﬂavonoids; Ant: anthraquinones; Ter: terpenes; Car Gly: cardiotonic gl by toxic concentration of extract. (B) Typical cytopathic effect observed in cells
iﬁcation, 20×).
Discussion
Our tests were conducted using a simple but very effective
model for detection of bioactive samples. Our strategy was to deter-
mine the working concentration of crude and fractionated extract,
and then determine the percentage inhibition of rotavirus replica-
tion in MA104 cells. The Simian rotavirus strain SA11 was  chosen
because this strain is well characterized as a group A rotavirus
and is one of the most widely used reference strains (Gutiérrez
et al., 2010). Rotaviruses are differentiated into seven groups (A–G).
Groups A, B, and C are associated with acute gastroenteritis in
humans and animals while groups D, E, F, and G only infect animals
(Saif and Jiang, 1994; Westerman et al., 2006; Estes and Greenberg,
2013). Besides, group A rotaviruses are the most common viral
agents causing diarrheal infections in children younger than three
years (Parashar et al., 2006; Junaid et al., 2011). These viruses are
internalized into MA104 cells showing typical cytopathic effects
(Malherbe and Strickland-Cholmley, 1967; López and Arias, 1992;
Gonc¸ alves et al., 2005; Logan et al., 2006; Gutiérrez et al., 2010;
Wolf et al., 2011) which are essential features for the success of our
test.
Rotaviruses are nonenveloped viruses composed of a triple-
layered protein capsid that surrounds the viral genome. Nonstruc-
tural glycoprotein 4 (NSP4) encoded by rotavirus is the only viral
protein currently believed to function as an enterotoxin. Identiﬁ-
cation of NSP4 as the ﬁrst viral enterotoxin is of interest because
it shows this protein has pleiotropic properties besides its intra-
cellular role in viral replication. The outermost layer is composed
of the protein VP7 and protruding spikes of trimeric VP4 (López
and Arias, 2006; Estes and Greenberg, 2013). The VP4 cleavage by
trypsin promotes rearrangements in the viral particles that rigidify
the spikes and is required for receptor binding and cell penetration
(López et al., 1985; Arias et al., 1996).
In our work, the chemical fractionation of the crude extract
resulted in ﬁve fractions, and one of them (F3) showed potential
antiviral activity with CPE inhibition at 50 g/ml (data not shown)
and a satisfactory PI (75%), although lower than the activity found
to the crude extract (PI = 100%). As expected, the fractionation pro-
duced samples with higher cytotoxicity due to the concentration
of some compound classes, forcing the evaluation of the antiviral
activity at lower concentrations than that used for the crude extract.
fractions (SF) from Myracrodruon urundeuva leaf.
Fla Ant Ter Car Gly  Alk
+ − + − −
− ND + ND ND
− ND + ND ND
+ ND + ND ND
+ ND − ND ND
+ ND − ND ND
+ ND + ND ND
ycosides; Alk: alkaloids; (+): presence; (−): absence; ND: not done.
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Ethical disclosuresFig. 2. Chromatographic proﬁle of crude extract MUL  (A) and
nterestingly, a further F3 fractionation yielded two active subfrac-
ions (SF1 and SF3) with PI values greater than F3 (92% and 80%,
espectively). In SF1, which showed the highest activity, ﬂavonoids
ere the major class of compounds found in addition to small
mounts of terpenes, as evidenced by TLC (data not shown) and
PLC proﬁles. The TLC analysis of this fraction showed predomi-
ance of spots with yellow ﬂuorescence under UV365nm light, which
as intensiﬁed with the use of NP/PEG spray reagent. This ﬁnding
as corroborated by the HPLC proﬁle, which showed peaks asso-
iated with UV spectra characteristic of ﬂavonoids and maximum
bsorption at ca. 275 and 350 nm (Fig. 2). Terpenes were evidenced
y the presence of spots of purple color when the TLC plate was
prayed with anysaldehyde/sulfuric acid and these compounds
ay be the responsible for the peaks observed in the chromatogram
f SF1 with retention times in the 40–65 min  range. The ﬁnal puriﬁ-
ation of the chemical constituents of SF1 was not performed due
o the low amount obtained for this sample (47 mg).
The antiviral activities of ﬂavonoids have been extensively
eported. Mass spectrometric data have demonstrated the pres-
nce of gallotannins in M.  urundeuva (Da Silva et al., 2011).
nterestingly, gallotannins are potent calcium-activated Cl− chan-
el inhibitors whose biological activity provides antisecretory
eneﬁts (Namkung et al., 2010). On the other hands, there are
vidences that NSP4, a nonstructural glycoprotein released from
otavirus-infected cells, induces the release of Ca2+ from the
ndoplasmic reticulum, resulting in increased paracellular perme-
bility in enterocytes, as well as increased secretion in the crypt
ells mediated by activation of Cl− transporter (Ramig, 2004).
hus, these ﬁndings point to a possible course of action for the
nti-rotavirus activity of M.  urundeuva.on SF1 (B) with UV spectra obtained online for peaks 1 and 2.
Another interesting ﬁnding in literature, which corroborates
with the potent antiviral effect of ﬂavonoid-enriched fraction SF1,
is the inhibitory activity related to several ﬂavonoids on reverse
transcriptases and proteases even at low concentrations (Ko et al.,
2009). Trypsin inhibitory activities have also recently been iden-
tiﬁed in ﬂavonoids extracted from orange peel and green tea
leaves (Shahwar et al., 2013). Since the infectivity of rotaviruses is
increased by trypsin and the viruses replicate primarily in intesti-
nal enterocytes during a natural infection, it is possible that the
ﬂavonoids present in SF1, may  be disrupting viral entry by a
protease inhibitor mechanism. Therefore, our data provide insights
for further studies with this ﬂavonoid-enriched subfraction, focus-
ing on the suppressive effect of viral ampliﬁcation in the early phase
of infection, and on an inhibitory activity on a possible mechanism
of action involving the NSP4 enterotoxin.
Finally, it is important to consider that a single compound could
not be responsible for the full antiviral activity and the combination
of compounds with balanced proportions in crude extract could be
acting in an additive or synergistic mode resulting in more effective
virucidal activity. These considerations encourage us to perform
additional studies with SF1 and MUL  using other complementary
tests in vitro and in vivo assay with murine rotavirus strains in
mice.Protection of human and animal subjects. The authors declare
that no experiments were performed on humans or animals for
this study.
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